Dermatological and metabolic benefits of semaglutide in psoriasis with obesity: a 6-month prospective cohort study

医学 银屑病 赛马鲁肽 前瞻性队列研究 社会心理的 队列研究 阿维A 皮肤病科 队列 疾病 内科学 临床试验 减肥 全身疗法 疾病严重程度 梅德林 糖尿病 儿科 免疫病理学 斑块性银屑病 物理疗法
作者
Joana Nicolau,Antoni Nadal,Pilar Sanchís,Antelm Pujol,María Isabel Tamayo,Guido Sfondrini,Miquel Grimalt Gelabert,Paula García,Cristina Nadal,Lluís Masmiquel
出处
期刊:Clinical and Experimental Dermatology [Oxford University Press]
卷期号:51 (3): 442-450 被引量:4
标识
DOI:10.1093/ced/llaf473
摘要

BACKGROUND: Psoriasis is a chronic inflammatory skin disease often associated with obesity and metabolic dysfunction, which may worsen disease severity. Glucagon-like peptide-1 receptor agonists, such as semaglutide, have shown metabolic and anti-inflammatory effects, but their impact on psoriasis in patients with obesity and without diabetes remains unclear. OBJECTIVES: To evaluate the effects of a 6-month semaglutide treatment on psoriasis severity and clinical, metabolic, inflammatory and psychosocial parameters in patients with psoriasis and obesity. METHODS: In this prospective cohort study, 43 patients received weekly semaglutide along with lifestyle counselling. Psoriasis severity (Psoriasis Area and Severity Index, PASI), quality of life (Dermatology Life Quality Index, DLQI), depressive symptoms (Beck Depression Inventory, BDI), nutritional ultrasound and biochemical markers were assessed at baseline and after 6 months. Correlations between PASI improvement (ΔPASI) and baseline variables and their changes were analysed, adjusting for age and weight loss. RESULTS: After 6 months, participants showed significant reductions in PASI (-48%), body mass index (BMI), preperitoneal and superficial fat, along with improvements in DLQI, BDI and metabolic markers. Baseline disease severity, depressive symptoms, insulin resistance and preperitoneal fat were negatively associated with PASI improvement. These associations remained significant after adjustment [e.g. Homeostatic Model Assessment for Insulin Resistance (HOMA-IR), r = -0.82; preperitoneal fat, r = -0.66]. ΔPASI was most strongly correlated with reductions in superficial fat (r = 0.89), DLQI (r = 0.55) and BDI (r = 0.51). Changes in BMI and glycaemic markers were not significantly associated after adjustment. CONCLUSIONS: In patients with psoriasis and obesity, semaglutide improves both skin disease and systemic health. The clinical benefit appears associated with specific fat loss and psychosocial improvement, beyond overall weight reduction.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
roro完成签到 ,获得积分10
1秒前
3秒前
3秒前
3秒前
顾矜的应助被RS采纳,获得10
5秒前
wg发布了新的文献求助10
5秒前
能干的人发布了新的文献求助30
5秒前
完美世界的应助被开心德地采纳,获得10
5秒前
HouShipeng发布了新的文献求助10
5秒前
5秒前
sinalpha10完成签到,获得积分20
6秒前
xr完成签到,获得积分10
6秒前
6秒前
6秒前
小蘑菇的应助被烂漫的诗双采纳,获得10
7秒前
香香鱼丸完成签到,获得积分10
7秒前
桴子完成签到,获得积分10
8秒前
SciGPT的应助被幸运周周周采纳,获得10
9秒前
9秒前
10秒前
12秒前
13秒前
13秒前
13秒前
小二郎的应助被qingshan采纳,获得10
13秒前
胖球球发布了新的文献求助10
14秒前
YanuoK发布了新的文献求助10
14秒前
啊呦阿柚完成签到,获得积分10
15秒前
zzyyqq发布了新的文献求助150
17秒前
17秒前
18秒前
18秒前
FashionBoy的应助被竟文采纳,获得10
19秒前
muderder发布了新的文献求助10
19秒前
20秒前
www完成签到,获得积分10
20秒前
彭于晏的应助被科研通管家采纳,获得10
20秒前
20秒前
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188371
求助须知:如何正确求助?哪些是违规求助? 9576179
关于积分的说明 21845965
捐赠科研通 7786421
什么是DOI,文献DOI怎么找? 3435292
关于科研通互助平台的介绍 2559601
邀请新用户注册赠送积分活动 2482276